Amphion Innovations plc is a principal investment firm specializing in both public and private early stage investments and spun out of universities and corporations. It does not invest in “speculative” technologies requiring long development timeframes or excessive capital investment. It invests in the medical, life sciences, and technology sectors with defensible core intellectual property, know-how and growth potential in very large markets of at least $1 billion in size together with corporations, governments, universities, and entrepreneurs. The firm typically invests in companies with broad-based, proprietary, platform technologies in the areas of pharmacogenomics, proteomics, nutriceut...
330 Madison Avenue
New York, NY 10017
Founded in 1984
Amphion Innovations plc Reports Unaudited Consolidated Earnings Results for the Six Months to June 30, 2013
Sep 24 13
Amphion Innovations plc reported unaudited consolidated earnings results for the six months to June 30, 2013. For the period, the company reported revenue was $264,638; roughly in line with the $326,412 recorded in the second half of 2012, but lower than the $1,069,394 recorded in the same period of last year. This decrease is a result of the intellectual property licensing programme stalling last year, which has remained so as it await the results for the Appeal of the Markman ruling as well the reduction in advisory fees. Operating loss was $1,025,023 against $1,469,194 for the same period a year ago. Loss before tax was $3,001,081 against profit before tax of $3,055,601 for the same period a year ago. Loss was $3,058,131 against profit of $2,999,601 for the same period a year ago. Net cash used in operating activities was $1,090,317 against $1,697,546 for the same period a year ago.
Kromek Mulls IPO
Sep 12 13
Amphion Innovations plc (AIM:AMP) announces that Kromek, Ltd. intends to float on the AIM market of the London Stock Exchange. Richard Morgan, Chief Executive Officer of Amphion and Chairman of Kromek, said, "Amphion was the first institutional investor to commit to Kromek in 2005, soon after its formation and spin-out from the University of Durham. Since then, we have been closely involved with its development and are delighted to see it is making the transition to a public company. We believe Kromek has substantial growth opportunities and this transition to the public markets should provide the needed capital to accelerate its growth while deepening and broadening its internal resources and external reach."
Amphion Innovations plc, Annual General Meeting, Aug 13, 2013
Aug 8 13
Amphion Innovations plc, Annual General Meeting, Aug 13, 2013.